Milind P Sovani

Summary

Publications

  1. ncbi Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?
    Milind P Sovani
    Division of Respiratory Medicine, University of Nottingham, Nottingham City Hospital
    Br J Gen Pract 58:37-43. 2008
  2. ncbi Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study
    Christopher I Whale
    Division of Respiratory Medicine, University of Nottingham, City Hospital, Nottingham, UK
    Br J Clin Pharmacol 65:841-7. 2008
  3. ncbi Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease
    Christopher I Whale
    Division of Respiratory Medicine, University of Nottingham, Nottingham City Hospital, Nottingham NG5 1PB, UK
    Br J Clin Pharmacol 62:153-7. 2006
  4. ncbi A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease
    Milind P Sovani
    Division of Respiratory Medicine, City Hospital, Nottingham, UK
    Drug Saf 27:689-715. 2004

Detail Information

Publications4

  1. ncbi Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?
    Milind P Sovani
    Division of Respiratory Medicine, University of Nottingham, Nottingham City Hospital
    Br J Gen Pract 58:37-43. 2008
    ..Poor adherence with inhaled corticosteroids is an important problem in asthma management. Previous approaches to improving adherence have had limited success...
  2. ncbi Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study
    Christopher I Whale
    Division of Respiratory Medicine, University of Nottingham, City Hospital, Nottingham, UK
    Br J Clin Pharmacol 65:841-7. 2008
    ..There are concerns with the overall safety of high-dose beta(2)-agonists in subjects with COPD, and this study looks at the balance of beneficial and adverse effects of a range of doses of inhaled formoterol...
  3. ncbi Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease
    Christopher I Whale
    Division of Respiratory Medicine, University of Nottingham, Nottingham City Hospital, Nottingham NG5 1PB, UK
    Br J Clin Pharmacol 62:153-7. 2006
    ..Our aim was to determine whether high dose nebulized rac-albuterol could increase P(a)CO(2) in patients with COPD, limited bronchodilator reversibilty and hypercapnia...
  4. ncbi A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease
    Milind P Sovani
    Division of Respiratory Medicine, City Hospital, Nottingham, UK
    Drug Saf 27:689-715. 2004
    ..Salmeterol 50 microg twice daily and formoterol 12 microg twice daily are effective and safe in treating patients with asthma and COPD. Higher doses cause more adverse effects, although serious adverse events are rare...